Tag - health-medicine

 
 

HEALTH MEDICINE

Kyoto University in the city of Kyoto. A research group at the university has developed a new type of protein that binds to unwanted cells to make it easier for immune cells to remove them.
JAPAN / Science & Health
Sep 8, 2025
Kyoto University develops protein to help remove cancer cells
The protein binds to unwanted cells to make it easier for immune cells to pick out their target for removal.
A measles alert sign is posted outside the entrance to the Cohen Children's Medical Center in New York in March.
COMMENTARY / World
Aug 25, 2025
‘Alternative facts’ aren't a reason to skip vaccines
Donald Trump’s health officials have been endorsing alternative facts in science to impose policies that contradict modern medical knowledge.
The World Health Organization's funding squeeze was sparked by the U.S. decision to leave the agency, announced on day one of Donald Trump’s presidency in January this year.
WORLD / Science & Health
Aug 22, 2025
WHO plans to relocate units and cease some work in wake of U.S. withdrawal
The organization cut its 2026-27 budget by 21% in May, has already halved its management team, and has seen over 400 staff depart since January.
A research team from Kyoto University has announced that it is the first in the world to create 3D jawbone-like organoids from human induced pluripotent stem, or iPS, cells.
JAPAN / Science & Health
Aug 19, 2025
Kyoto University group successfully creates jawbone from iPS cells
The team expects that its method will be applied to regenerative medicine and drug discovery.
U.S. Health Secretary Robert F. Kennedy Jr.’s decision to cancel funding for mRNA vaccine development dismantles an important public health tool and could weaken America’s ability to respond to future pandemics.
COMMENTARY
Aug 8, 2025
RFK Jr.’s mRNA decision may be his worst yet
U.S. Health Secretary RFK Jr.’s decision to cancel funding for mRNA vaccine development dismantles a public health tool and could weaken the ability to respond to future pandemics.
The newly developed drug, Adriana, is a groundbreaking painkiller, which works on a completely different mechanism to morphine and other existing synthetic opioids.
JAPAN
Aug 5, 2025
Kyoto University team develops pain reliever comparable to morphine
Morphine, often administered to cancer patients, can cause serious adverse effects such as breathing issues and addiction.
A screenshot of a health ministry website shows an application form to submit documents for approval of a regenerative medicine program.
JAPAN / Science & Health
Jul 28, 2025
Health bureaus' inconsistencies on regenerative medicine plans spark outcry
In one case, a regional health and welfare bureau immediately approved a regenerative medicine program but a different bureau rejected the same treatment plan.
Senate Republicans must undo their reckless confirmation of Robert F. Kennedy Jr. as health secretary, whose anti-vaccine crusade is fueling a deadly measles outbreak and putting more Americans at risk.
COMMENTARY / World
Jul 25, 2025
RFK Jr. is making America sick again. Republicans need a cure.
Kennedy, who has no training in medicine or health, has long been the nation’s foremost peddler of junk science and the crackpot conspiracy theories that flow from it.
A breakthrough HIV prevention drug, lenacapavir, offers hope to end the epidemic, but U.S. President Donald Trump’s cuts to global health funding threaten access and rollout, especially in Africa where prevention efforts are already strained.  
COMMENTARY / World
Jul 8, 2025
When an HIV scientific breakthrough isn’t enough
Trump administration funding cuts and dismantling of USAID force a shift from HIV elimination back to treatment.
The U.S. and the world will become unhealthier and vast numbers of children may die now that Donald Trump’s health secretary, Robert F. Kennedy Jr., has pulled funding from the global vaccine program GAVI. 
COMMENTARY / World
Jul 7, 2025
RFK Jr. is playing with babies’ lives
Robert F. Kennedy Jr.’s cut to U.S. funding for GAVI risks lives globally and damages America’s international standing.
The U.S. Food and Drug Administration's new plan to restrict updated COVID-19 vaccines to high-risk groups has sparked confusion and criticism, with experts warning it could limit public access and bypass established advisory channels.
COMMENTARY / World
May 26, 2025
The FDA’s new COVID-19 vaccine policy is clear as mud
The U.S. health agency's promises of transparency and choice for COVID-19 vaccines fall short in its first big test. 
This undated image shows cardiologist Kiran Musunuru and pediatrician Rebecca Ahrens-Nicklas with patient KJ Muldoon.
WORLD / Science & Health
May 16, 2025
U.S. baby with rare illness treated with tailor-made gene edit
The baby, who had a gene mutation that affected his liver, was treated using what amounts to a pair of molecular scissors, delivered via an infusion.
A group of researchers including from Kyoto University confirmed that the TIM-3 protein, which exists in a type of immune cell in the brain, increases as the brain ages.
JAPAN / Science & Health
May 8, 2025
Loss of immune-regulating protein seen easing Alzheimer's disease
The findings are expected to help develop a new treatment for the disease.
A new U.S. FDA policy requiring full placebo-controlled trials for updated vaccines, pushed by Commissioner Marty Makary (right) and U.S. HHS Secretary Robert F. Kennedy Jr. (center), is seen as a backdoor effort to sideline COVID-19 boosters and undermine broader vaccine development.
COMMENTARY / Japan
May 2, 2025
RFK Jr.’s new vaccine scrutiny is alarming
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly meet.
Since the 1990s, Parkinson's disease researchers have aimed to use stem cells to replace lost neurons, and they're now finding the right cues to turn them into dopamine-producing cells.
COMMENTARY / World
Apr 30, 2025
Finally, a source of hope for Parkinson’s disease sufferers
The treatments were originally developed by a team at Memorial Sloan Kettering Cancer Center in New York and the other by researchers in Kyoto.
Shares of Eli Lilly & Co. surged on the New York Stock Exchange on Thursday after early reports of its experimental weight-loss drug put in a par with market leader Ozempic. The stocks of the drug’s originator, Chugai Pharmaceutical Co., also saw an uptick.
BUSINESS / Companies
Apr 18, 2025
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
Eli Lilly’s orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows.
Parkinson's disease is a neurodegenerative condition in which motor function is impaired due to a decrease in nerve cells that produce dopamine, a chemical that works in the brain.
JAPAN / Science & Health
Apr 17, 2025
Japan succeeds in improving Parkinson's symptoms with iPS cells
A trial saw nerve cells made from iPS cells transplanted into patients' brains.
The Trump administration has slashed LGBTQ+ health research funding, dismantling key programs and halting studies on disparities and mental health, which experts warn will reverse progress and harm vulnerable communities.
COMMENTARY
Apr 14, 2025
The very idea of LGBTQ+ health is under attack
The Trump administration is rapidly breaking down the research infrastructure for these communities and doing so in a manner that guarantees it can’t be restored.
U.S. molecular biologist David Liu in 2017. A revolution is underway in gene editing, and at its forefront is Liu, whose pioneering work is rewriting the building blocks of life with unprecedented precision.
WORLD / Science & Health
Apr 7, 2025
The scientist rewriting DNA, and the future of medicine
American molecular biologist David Liu foresees his work to also contribute to areas such as developing more nutritious or disease-resistant crops.
A doctor administers COVID-19 vaccinations to members of the Latino community in Bensalem, Pennsylvania, in August 2021.
WORLD / Science & Health
Apr 5, 2025
As U.S. ditches diversity in clinical trials, all eyes on Europe
The United States once led the world in running clinical trials that aimed to look like the nation at large.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’